Summary & Overview
HCPCS Q4294: Amnio Quad-Core, Per Square Centimeter (Add-On)
HCPCS Level II code Q4294 designates an add-on billing unit for an amnio quad-core measured per square centimeter. As an add-on code, it is billed in addition to a primary procedure when amniotic membrane tissue is processed or sampled for therapeutic or laboratory use. Nationally, accurate use of add-on area-based codes like Q4294 matters for clinical documentation, correct payment linkage to the primary service, and consistent reporting across sites that process biologic tissues.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for the code, the typical sites of service where it is applied, and which payers are relevant for coverage considerations. The publication provides benchmarks and policy-oriented notes where available, clarifies billing practice implications of an add-on per-square-centimeter code, and highlights documentation elements that are commonly necessary for reimbursement review.
This summary is written for a national audience and focuses on what the code represents, how it functions as an add-on to primary procedures, and what stakeholders should expect when encountering Q4294 on service lines and claims.
Billing Code Overview
HCPCS Level II code Q4294 describes amnio quad-core, per square centimeter (add-on, list separately in addition to primary procedure). This code represents an add-on laboratory or pathology itemized component measured by area, used when an amniotic membrane product is processed or core-sampled in a way that requires square-centimeter billing.
Service Type: Laboratory / Tissue Processing Add-on Service
Typical Site of Service: Outpatient surgical centers, hospital outpatient departments, and specialized tissue processing laboratories
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A pregnant patient at approximately mid-gestation with a history of membrane compromise or risk factors for amniotic membrane insufficiency presents for operative management of a complex wound involving the fetal membranes or an obstetric surgical site where topical amniotic membrane grafting is indicated. The typical workflow begins with preoperative assessment in an outpatient maternal-fetal medicine or obstetrics clinic, documentation of indications and informed consent, and coordination with the surgical team. In the operating room or procedure suite, after primary procedure preparation (for example, cesarean delivery revision, pelvic reconstructive surgery, or repair of an iatrogenic membrane defect), the clinician measures the area requiring grafting and applies an Q4294 amnio quad-core graft on a per square centimeter basis as an add-on to the primary procedure. The procedure frequently involves sterile placement of the graft, fixation as needed, and intraoperative documentation of graft size in square centimeters. Post-procedure, the patient is monitored in the recovery area with routine wound checks and obstetric follow-up to assess graft integration, membrane integrity, and fetal well-being when applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when the work required to place the amnio graft is substantially greater than typical due to complexity or extensive additional time. |